Showing results (101-110 of 2,363) with videos related to
Sort By:
Pageof 237
British Journal of Clinical Pharmacology|October 1, 1984
Is N-acetylation of 5-aminosalicylic acid reversible in man?C O Meese, C Fischer, U KlotzInternational Journal of Clinical Pharmacology and Biopharmacy|April 1, 1979
Disposition and antiarrhythmic effect of lorcainideU Klotz, P Müller-Seydlitz, P HeimburgBritish Journal of Clinical Pharmacology|November 1, 1986
Does the benzodiazepine antagonist Ro 15-1788 antagonize the action of ethanol?U Klotz, G Ziegler, B Rosenkranz, et al.European Journal of Clinical Pharmacology|January 1, 1990
Ivermectin binds avidly to plasma proteinsU Klotz, J E Ogbuokiri, P O OkonkwoClinical Pharmacology and Therapeutics|May 1, 1996
Disposition and first-pass metabolism of ethanol in humans: is it gastric or hepatic and does it depend on gender?E Ammon, C Schäfer, U Hofmann, et al.Gut|May 1, 1993
Oroileal transit of slow release 5-aminosalicylic acidH Goebell, U Klotz, B Nehlsen, et al.Clinical Pharmacology and Therapeutics|December 1, 1982
Effects of cimetidine and ranitidine on steady-state propranolol kinetics and dynamicsI W Reimann, U Klotz, J C FrölichDeutsche Medizinische Wochenschrift (1946)|July 23, 1982
[5-Aminosalicylic acid in ulcerative colitis and Crohn's disease (author's transl)]K Maier, C Fischer, U Klotz, et al.Medizinische Klinik (Munich, Germany : 1983)|June 19, 1998
[Significance of galenic preparations for luminal release of 5-aminosalicylic acid in human small intestinal lumen]J Keller, H Goebell, U Klotz, et al.Helicobacter|August 8, 2002
Impact of furazolidone-based quadruple therapy for eradication of Helicobacter pylori after previous treatment failuresG Treiber, S Ammon, P Malfertheiner, et al.Pageof 237